Adam D. Levy, CFO of Acrivon Therapeutics ACRV, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $15K. The latest trade was on 05/18.

AL

AL

Adam D. Levy

CFO

Company

Acrivon Therapeutics ACRV

First filing

25/04/03

Trades

5 trades

Buys / sales

1 / 0

12-month net buying

$15K

Last trade

05/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Acrivon TherapeuticsACRV	Open-market buy	01/14	01/16	8,832 sh	$1.70	$15,014.4	+72.7%